ATE143012T1 - Piperazinderivate - Google Patents

Piperazinderivate

Info

Publication number
ATE143012T1
ATE143012T1 AT91309513T AT91309513T ATE143012T1 AT E143012 T1 ATE143012 T1 AT E143012T1 AT 91309513 T AT91309513 T AT 91309513T AT 91309513 T AT91309513 T AT 91309513T AT E143012 T1 ATE143012 T1 AT E143012T1
Authority
AT
Austria
Prior art keywords
piperazine derivatives
rsqbstr
lsqbstr
phenylbutyryl
azepin
Prior art date
Application number
AT91309513T
Other languages
English (en)
Inventor
Ian Anthony Cliffe
Original Assignee
Wyeth John & Brother Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth John & Brother Ltd filed Critical Wyeth John & Brother Ltd
Application granted granted Critical
Publication of ATE143012T1 publication Critical patent/ATE143012T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Indole Compounds (AREA)
AT91309513T 1990-10-19 1991-10-16 Piperazinderivate ATE143012T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909022820A GB9022820D0 (en) 1990-10-19 1990-10-19 Piperazine derivatives

Publications (1)

Publication Number Publication Date
ATE143012T1 true ATE143012T1 (de) 1996-10-15

Family

ID=10684053

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91309513T ATE143012T1 (de) 1990-10-19 1991-10-16 Piperazinderivate

Country Status (15)

Country Link
EP (1) EP0481744B1 (de)
JP (1) JP3007203B2 (de)
KR (1) KR100193928B1 (de)
AT (1) ATE143012T1 (de)
AU (1) AU642044B2 (de)
CA (1) CA2053709C (de)
DE (1) DE69122205T2 (de)
DK (1) DK0481744T3 (de)
ES (1) ES2091879T3 (de)
GB (2) GB9022820D0 (de)
GR (1) GR3021221T3 (de)
HU (2) HU212943B (de)
IE (1) IE65379B1 (de)
NZ (1) NZ240271A (de)
PT (1) PT99251B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9125900D0 (en) * 1991-12-05 1992-02-05 Wyeth John & Brother Ltd Piperazine derivatives
JPH08501287A (ja) * 1992-08-05 1996-02-13 ジョン・ワイス・アンド・ブラザー・リミテッド アミド誘導体
GB9221931D0 (en) * 1992-10-17 1992-12-02 Wyeth John & Brother Ltd Piperazine derivatives
GB2271930B (en) * 1992-11-03 1996-07-24 Wyeth John & Brother Ltd Pharmaceutical piperazine derivatives
GB9223153D0 (en) * 1992-11-05 1992-12-16 Wyeth John & Brother Ltd Piperazine derivatives
GB9303968D0 (en) * 1993-02-26 1993-04-14 Wyeth John & Brother Ltd 5-ht1a ligands
GB9304632D0 (en) * 1993-03-06 1993-04-21 Wyeth John & Brother Ltd Amide derivatives
US5609849A (en) * 1994-03-11 1997-03-11 The Trustees Of The University Of Pennsylvania Serotonin (5-HT1A) receptor ligands and imaging agents
GB9419024D0 (en) * 1994-09-21 1994-11-09 Wyeth John & Brother Ltd Bicyclic carboxamides
GB9525239D0 (en) * 1995-12-09 1996-02-07 American Home Prod Medical treatment
FR2744448B1 (fr) * 1996-02-02 1998-04-24 Pf Medicament Nouvelles piperidines derivees d'aryl piperazine, ainsi que leur procede de preparation, les compositions pharmaceutiques et leur utilisation comme medicaments
US5990114A (en) * 1996-02-28 1999-11-23 Recordati, S.A., Chemical And Pharmaceutical Company Use of 5-HT1A receptor antagonists for the treatment of urinary incontinence
ITMI20021327A1 (it) * 2002-06-14 2003-12-15 Recordati Chem Pharm Nuove ossialchilpiperazine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2776282A (en) * 1954-05-04 1957-01-01 Searle & Co Cyclic amides of alpha-toluic acids and derivatives thereof
GB8909209D0 (en) * 1989-04-22 1989-06-07 Wyeth John & Brother Ltd Piperazine derivatives
IL94151A (en) * 1989-04-22 1995-08-31 Wyeth John & Brother Ltd History of piperazine, their preparation and pharmaceutical preparations containing them
AU644488B2 (en) * 1990-10-19 1993-12-09 John Wyeth & Brother Limited Piperazine derivatives

Also Published As

Publication number Publication date
GB2248836B (en) 1994-05-04
HUT60264A (en) 1992-08-28
PT99251A (pt) 1992-08-31
EP0481744B1 (de) 1996-09-18
ES2091879T3 (es) 1996-11-16
CA2053709C (en) 2001-12-11
DE69122205T2 (de) 1997-01-30
IE913669A1 (en) 1992-04-22
EP0481744A1 (de) 1992-04-22
KR920008019A (ko) 1992-05-27
HU913292D0 (en) 1992-01-28
AU8592091A (en) 1992-04-30
HU212943B (en) 1996-12-30
DK0481744T3 (da) 1996-10-07
CA2053709A1 (en) 1992-04-20
JP3007203B2 (ja) 2000-02-07
KR100193928B1 (ko) 1999-06-15
GB9118744D0 (en) 1991-10-16
NZ240271A (en) 1993-03-26
IE65379B1 (en) 1995-10-18
DE69122205D1 (de) 1996-10-24
HU211587A9 (en) 1995-12-28
PT99251B (pt) 1999-04-30
GB9022820D0 (en) 1990-12-05
GR3021221T3 (en) 1997-01-31
AU642044B2 (en) 1993-10-07
GB2248836A (en) 1992-04-22
JPH04282371A (ja) 1992-10-07

Similar Documents

Publication Publication Date Title
DE69122205D1 (de) Piperazinderivate
FI960364L (fi) Uusia 1,4-(difenyylialkyyli)piperatsiinijohdoksia
ATE138921T1 (de) Xanthinderivate
NO304071B1 (no) Heterocyklisk-cykliske amin-derivater
DK0590428T3 (da) Azaquinoxaliner, fremgangsmåde til deres fremstilling og deres anvendelse
FI933804A0 (fi) Monohydrat av 5-(2-(4-(1,2-bensisotiazol-3-yl)-1-piperazinyl)etyl-6-klor-1,3-dihydro-2h-indol-2-onkhydroklorid
ATE113282T1 (de) Heteroaryl piperazine als antipsychotische mittel.
SE8600174L (sv) Nytt forfarande for framstellning av n-(2-pyrimidinyl)-piperazinylalkylazaspiroalkandioner
DE69106388D1 (de) Antipsychotische 4-(1,2-benzisoazolyl)piperidinderivate.
ATE213943T1 (de) Verwendung von piperazin-acetamid-derivaten gegen reperfusionsschaden
ITMI911520A1 (it) Derivati di piperidina, loro preparazione e uso
NZ216750A (en) Morpholino derivatives and fungicides
ATE188693T1 (de) 2-(4-(4-azolylbutyl)-1-piperazinyl)-5- hydroxypyrimidin-derivate, deren herstellung und deren verwendung als heilmittel
ATE139523T1 (de) Neue verbindungen und deren medizinale verwendung
MX9205186A (es) Derivados de 4-[4-[4-(4-hidroxifenil)-1-piperazinil]-fenil]-5-metil-3h-1,2,4-triazo l-3-ona
MY110446A (en) Piperazine derivatives
FI870925L (fi) 4-(2-pyrimidinyl)-1-piperazinyl -heterocykliska karbonylderivater.
MX9201297A (es) Derivados piperacinicos y procedimiento para su preparacion.
DE69523346D1 (de) Substituierte 6-h-1,3,4-thiadiazin-2-amine, deren verwendung als anaesthetisierende cardiovaskulare und hypometabole mittel, und eine sie enthaltende pharmazeutische zubereitung
DE50100396D1 (de) (+)- und (-)-2-Cyclododecylpropanol und (+)- und (-)-2-Cyclododecylpropionsäure sowie deren Herstellung und Verwendung
DE69307769D1 (de) Neue Verwendung von (S) Amino-2-dichloro-3,4-benzyl)-2-propanol-1 Enantiomere Derivate
FI920945L (fi) Menetelmä terapeuttisesti käyttökelpoisen 2,3,4,5,6,7-heksahydro-1-(4- 1-/4-(2-metoksifenyyli)piperatsinyyli/ -2-fenyylibutyryyli)-1H-atsepiinin tai sen farmaseuttisesti hyväksyttävän happoadditiosuolan valmis tamiseksi

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee